Home » Newsletters » BioWorld Science

BioWorld Science

March 19, 1997

View Archived Issues

Cephalon discloses cysteine/serine protease inhibitors

Antitumor/antiviral distamycin derivatives from P&U

Fujisawa prepares PLA2 inhibitors

Dual TNF/PDE IV inhibitors from SKB

Natural squalene synthase inhibitors discovered by Pfizer

COX-2 inhibitors disclosed by Hafslund Nycomed

BioChem Pharma synthesizes opioid analgesics/NMDA antagonists

PGI2 agonists described by Fujisawa

Medco and University of Ferrara collaborate on adenosine-based compounds

Sheffield to acquire St. Louis-based pharmaceutical company

Pivotal trial data reported for levalbuterol

Company Profile: BioDelivery Sciences

Aggrastat prevents heart attack, death and other complications in unstable angina

Calypte submits clinical data to FDA on HIV-1 antibody test

FDA approves Ohmeda's neuromuscular blocking agent

Sparta L.A.D.D. technology covered by U.S. patent

In vivo capability of GeneSwitch technology demonstrated

Alternative to bypass surgery presented at ACC meeting

Gastric prokinetic agent developed by Kyorin

InTIME trial indicates nPA superior to tPA in MI

Cardioprotective effects of KBR-9032

Reduced risk of mortality found for losartan in ELITE study

JT characterizes novel COX-2 inhibitor

Novel Na+/H+-exchange inhibitor from Fujisawa with cardioprotective effects

Tretinoin gel launched in the U.S.

Antihyperalgesic effects of bradykinin B2 antagonist from Fujisawa

Pharm-Eco to manufacture Inflazyme's Apanol

Eisai discovers novel selective PDE I inhibitor

Cabergoline launched in U.S.

Favorable phase III results reported for Cytolex

Wyeth-Ayerst acquires commercialization rights to rhIL-11

Lilly and Kyowa Hakko enter combinatorial chemistry collaboration

Zila to acquire Cygnus Imaging

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...